A Study of the Efficacy and Safety of Pregabalin for the Treatment of Diabetic Peripheral Neuropathy or Postherpetic Neuralgia

Viatris

Status and phase: Completed; Phase 4

Conditions: Painful Diabetic Neuropathy and Post Herpetic Neuralgia

Treatments: Drug: Pregabalin

Study type: Interventional

Funder types: Industry

Identifiers

NCT00629681

A0081031

Details and patient eligibility

About

The purpose of this study is to assess the efficacy and safety of pregabalin for the treatment of diabetic peripheral neuropathy (DPN) or postherpetic neuralgia (PHN)

Enrollment: 217 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of DPN or PHN
• Score on the Numeric Rating Scale of at least 4/10

Exclusion criteria

• Hospitalized patients
• Neurologic disorders unrelated to DPN or PHN or any severe pain that may confound the assessment of DPN- or PHN-related pain

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

217 participants in 1 patient group

1

Experimental group

Treatment:

Drug: Pregabalin